🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Elgene Lim

Garvan Institute of Medical Research

ORCID: 0000-0001-8065-8838

Also affiliated with UNSW Sydney, St Vincent's Hospital Sydney

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer”.

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1796
N/A
0.680DataRank · unranked
24 citations

Meritxell Bellet, Nicholas C. Turner, Sherene Loi, Aditya Bardia, Valentina Boni +17 more

XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway

UNC Libraries(2020)10.17615/qv76-mh95
N/A
0.104DataRank · unranked
1 citations

Wai Leong Tam, X. Shirley Liu, Sandra J. Shin, Myles Brown, Jenny C. Chang +19 more

PO-1034: Chemoradiation-induced intratumoral immune microenvironment changes in oesophageal cancer

Radiotherapy and Oncology(2020)10.1016/s0167-8140(21)01051-3
N/A
0DataRank · unranked
0 citations

Joe Yeong, Wei Qiang Leow, L.M. Wang, L.A.L. Lee, Tony Kiat Hon Lim +20 more

The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer

Nature Medicine(2021)10.1038/s41591-020-01168-7
N/A
0DataRank · unranked
254 citations

Luke A. Selth, Kee Ming Chia, Geraldine Laven‐Law, Heloisa Milioli, Daniel Roden +19 more

Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2975
N/A
0DataRank · unranked
35 citations

Agostina Nardone, Douglas Russo, Zsuzsanna Nagy, Capucine Héraud, Albert Grinshpun +26 more

Data from Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

(2024)10.1158/1078-0432.c.7077719
N/A
0DataRank · unranked
0 citations

Meritxell Bellet, Nicholas C. Turner, Sherene Loi, Aditya Bardia, Valentina Boni +17 more

Data from Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

(2024)10.1158/1078-0432.c.7077719.v1
N/A
0DataRank · unranked
0 citations

Meritxell Bellet, Nicholas C. Turner, Sherene Loi, Aditya Bardia, Valentina Boni +17 more